Recruiting
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
NCT05408221
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Huizhou Central People's Hospital Guandong, China
- Jinan Central Hospital Shandong, China
- Linyi Cancer Hospital Shandong, China